Tag: pharmaceuticals
-
Large Trial Testing Covid-19 Antibody Therapies
A clinical trial conducted by National Institutes of Health is evaluating two more synthetic antibodies as treatments for patients hospitalized with Covid-19 infections.
-
Neuroscience Biotech Acquired in $770M Deal
A three year-old biotechnology company developing treatments for psychiatric and movement disorders is being acquired by global drug maker Novartis.
-
Trial Testing Ultrasound, Chemo for Brain Tumors
A clinical trial is underway assessing an implanted ultrasound device with chemotherapy to treat glioblastoma, an aggressive form of brain cancer.
-
ALS Stem Cell Treatments Found Safe, Slow Progression
Results from an early clinical trial of stem cells to treat amyotrophic lateral sclerosis, or ALS, shows the therapy is safe and slows progression of the disease.
-
AbbVie Acquires Coronavirus Antibody Therapy
Drug maker AbbVie is licensing a synthetic antibody to treat Covid-19 and SARS coronaviruses that the company began funding in June.
-
Biotech Licenses Precision Cancer Biologic to Genentech
A biotechnology company discovering synthetic proteins that target cancer-causing genetic mutations is licensing its lead product to biologics maker Genentech.
-
Infographic – Rich Nations Buy Most Covid-19 Vaccines
U.S., European Union, and five other countries, representing 14 percent of the world’s population, already bought up 53 percent of initial supplies of Covid-19 vaccine doses.
-
Covid-19 Antibody Developer Raises $483M in IPO
A biotechnology company developing therapeutic antibodies for Covid-19 infections is raising $483 million in its initial public offering of common stock.
-
University Halts Covid-19 Vaccine Trials
An Australian university is stopping development of a vaccine to prevent Covid-19 infections due to antibodies from the vaccine that interfere with HIV tests.
-
Daily Covid-19 Nasal Spray Vaccine in Works
A group of university and government labs is formulating an antiviral drug as a nasal spray for use as a daily preventive vaccine against Covid-19 infections.